Amgen (AMGN) Total Debt (2009 - 2025)

Amgen (AMGN) has reported Total Debt for 16 consecutive years, with $54.6 billion the latest figure, recorded in FY2025.

• In Q1 2026, Total Debt changed 0.1% year-over-year to $57.3 billion; the TTM figure through Mar 2026 stood at $57.3 billion (changed 0.1% YoY), while the FY2025 annual figure was $54.6 billion, down 9.14% from the prior year.
• Total Debt came in at $54.6 billion for FY2025 at Amgen, down from $60.1 billion in the prior year.
• The five-year high for Total Debt was $64.6 billion in FY2023, with the low at $33.3 billion in FY2021.
• Average Total Debt over 5 years is $50.3 billion, with a median of $54.6 billion recorded in 2025.
• Across the five-year window, Total Debt soared 65.91% in 2023 and fell 9.14% in 2025, its largest moves.
• Year by year, Total Debt stood at $33.3 billion in 2021, then rose by 16.92% to $38.9 billion in 2022, then jumped by 65.91% to $64.6 billion in 2023, then fell by 6.99% to $60.1 billion in 2024, then retreated by 9.14% to $54.6 billion in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $54.6 billion, $60.1 billion, and $64.6 billion for FY2025, FY2024, and FY2023 respectively.